Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26547139 | 0.89 | CA1 (0.31) | CA1CA2CA4CA12CA7 | |
| SCHEMBL24610552 | 0.83 | POLB (0.35) | — | |
| Tert-Butylamine SCHEMBL6281054 | 0.79 | CA1 (0.40) | CA1CA2CA4CA12CA7 | |
| SCHEMBL12236814 | 0.78 | CA1 (0.36) | CA1CA2CA4CA12CA7 | |
| SCHEMBL18614947 | 0.78 | CA1 (0.31) | CA1CA2CA4CA12CA7 | |
| SCHEMBL6233289 | 0.78 | ALDH1A1 (0.37) | CA1CA2SMN1; SMN2TDP1CES2 | |
| SCHEMBL22468667 | 0.78 | ALDH1A1 (0.37) | CA1CA2SMN1; SMN2TDP1CES2 | |
| SCHEMBL24015393 | 0.78 | — | — | |
| SCHEMBL17998022 | 0.77 | — | — | |
| SCHEMBL10212111 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114671976-B | Non-conjugated organic polymer containing nitroxide free radical and ferrocene group, preparation method and application thereof, and composite thermoelectric film | 香港理工大学深圳研究院 | 2023-12-19 | — | — | CN | disclosed |
| CN-114671976-B | Non-conjugated organic polymer containing nitroxide free radical and ferrocene group, preparation method and application thereof, and composite thermoelectric film | 香港理工大学深圳研究院 | 2023-12-19 | — | — | CN | disclosed |
| US-20230329095-A1 | Novel Compound, Coating Composition Comprising Same, Organic Light-Emitting Device Using Same, and Manufacturing Method Therefor | LG CHEM, LTD. (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230312803-A1 | POLYURETHANE COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC | 2023-10-05 | — | — | US | disclosed |
| US-20230312803-A1 | POLYURETHANE COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC | 2023-10-05 | — | — | US | disclosed |
| US-11672867-B2 | Protein-templated self-assembly of a covalent polymer network for intracellular trafficking and traceless release | UNIVERSITY OF MASSACHUSETTS (US) | 2023-06-13 | — | — | US | disclosed |
| US-11672867-B2 | Protein-templated self-assembly of a covalent polymer network for intracellular trafficking and traceless release | UNIVERSITY OF MASSACHUSETTS (US) | 2023-06-13 | — | — | US | disclosed |
| US-20230128198-A1 | NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS AURORA A SELECTIVE INHIBITORS | JACOBIO PHARMACEUTICALS CO., LTD (CN) | 2023-04-27 | — | — | US | disclosed |
| US-20230128198-A1 | NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS AURORA A SELECTIVE INHIBITORS | JACOBIO PHARMACEUTICALS CO., LTD (CN) | 2023-04-27 | — | — | US | disclosed |
| CN-114671976-A | Non-conjugated organic polymer containing nitroxide free radicals and ferrocene groups, preparation method and application thereof, and composite thermoelectric film | 香港理工大学深圳研究院 | 2022-06-28 | — | — | CN | disclosed |
| US-20160200730-A1 | POLYFLUORINATED COMPOUNDS ACTING AS BRUTON TYROSINE KINASE INHIBITORS | Zhejiang DTRM Biopharma Co. Ltd. (CN) | 2016-07-14 | — | — | US | disclosed |
| US-20120142711-A1 | ACID-LABILE TRIGGER UNITS | KTB TUMORFORSCHUNGSGESELLSCHAFT MBH (DE) | 2012-06-07 | — | — | US | disclosed |
| US-20100215735-A1 | Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds | MULLAN MICHAEL J | 2010-08-26 | — | — | US | disclosed |
| US-20100216784-A1 | Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds | MULLAN MICHAEL J | 2010-08-26 | — | — | US | disclosed |
| US-20090176858-A1 | HCV PROTEASE INHIBITORS AND USES THEREOF | AVILA THERAPEUTICS, INC. (US) | 2009-07-09 | — | — | US | disclosed |
| US-7402674-B2 | 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments | SANOFI-AVENTIS DEUTSCHLAND GMBH, (DE) | 2008-07-22 | — | — | US | disclosed |
| US-7402674-B2 | 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments | SANOFI-AVENTIS DEUTSCHLAND GMBH, (DE) | 2008-07-22 | — | — | US | disclosed |
| US-20080058330-A1 | Compounds and Combinations Thereof for Inhibiting Beta-Amyloid Production and Methods of Use Thereof | ROSKAMP RESEARCH LLC (US) | 2008-03-06 | — | — | US | disclosed |
| US-20070185130-A1 | Compounds for inhibiting beta-amyloid production and methods of identifying the compounds | ROSKAMP RESEARCH LLC | 2007-08-09 | — | — | US | disclosed |
| US-20070037855-A1 | Compounds for inhibiting beta-amyloid production and methods of identifying the compounds | ALZHEIMER'S INSTITUTE OF AMERICA, INC. | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058330-A1 | Compounds and Combinations Thereof for Inhibiting Beta-Amyloid Production and Methods of Use Thereof | APP, PSEN1, PSEN2 | CA1 118/4885CA2 189/4885CA4 1647/4885 |
| US-20160200730-A1 | POLYFLUORINATED COMPOUNDS ACTING AS BRUTON TYROSINE KINASE INHIBITORS | BTK, LCK, LYN | CA1 4806/4885CA2 3455/4885CA4 3970/4885 |
| US-20090176858-A1 | HCV PROTEASE INHIBITORS AND USES THEREOF | PEPD, CTRL, CTSC | CA1 3888/4885CA2 3859/4885CA4 2228/4885 |
| US-11672867-B2 | Protein-templated self-assembly of a covalent polymer network for intracellular trafficking and traceless release | CCL2, ACTB, TIA1 | CA1 3636/4885CA2 4113/4885CA4 4393/4885 |
| US-20120142711-A1 | ACID-LABILE TRIGGER UNITS | ASIC1, ABL1, CA9 | CA1 8/4885CA2 24/4885CA4 9/4885 |
| US-20070185130-A1 | Compounds for inhibiting beta-amyloid production and methods of identifying the compounds | APP, PSEN1, PSEN2 | CA1 169/4885CA2 142/4885CA4 1807/4885 |
| US-20070037855-A1 | Compounds for inhibiting beta-amyloid production and methods of identifying the compounds | APP, PSEN1, PSEN2 | CA1 169/4885CA2 142/4885CA4 1807/4885 |
| US-20230329095-A1 | Novel Compound, Coating Composition Comprising Same, Organic Light-Emitting Device Using Same, and Manufacturing Method Therefor | NOTUM, OR51E2, ORMDL3 | CA1 2353/4885CA2 4517/4885CA4 2589/4885 |
| US-20230128198-A1 | NOVEL HETEROCYCLIC COMPOUNDS USEFUL AS AURORA A SELECTIVE INHIBITORS | AURKA, AURKC, AURKB | CA1 3490/4885CA2 1550/4885CA4 2683/4885 |
| US-20100216784-A1 | Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds | APP, PSEN1, PSEN2 | CA1 169/4885CA2 142/4885CA4 1807/4885 |
| US-20100215735-A1 | Compounds for Inhibiting Beta-Amyloid Production and Methods of Identifying the Compounds | APP, PSEN1, PSEN2 | CA1 169/4885CA2 142/4885CA4 1807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.